Filter
678
Text search:
medicine
manufacturing
Featured
Recommendations
54
New Publications
175
Language
Document type
No document type
328
Studies & Reports
142
Guidelines
114
Manuals
36
Strategic & Response Plan
30
Fact sheets
13
Situation Updates
8
Training Material
3
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
34
Kenya
29
Ethiopia
19
Global
19
Nigeria
18
Ghana
17
Uganda
16
Nepal
13
Tanzania
13
South Africa
12
Bangladesh
12
Western and Central Europe
11
Sierra Leone
10
Zambia
10
Philippines
9
Liberia
8
South–East Asia Region
8
Zimbabwe
7
Rwanda
7
Malawi
7
Lesotho
7
Myanmar / Burma
6
East and Southern Africa
6
Indonesia
5
Namibia
5
Ukraine
5
West and Central Africa
5
Africa
5
USA
4
Haiti
4
Syria
4
Cambodia
4
Thailand
4
Eswatini/ Swaziland
4
Congo, Democratic Republic of
3
Cameroon
3
Pakistan
3
Botswana
3
Sri Lanka
3
Latin America and the Carribbean
3
Asia
3
Eastern Europe
3
Albania
3
Guinea
2
Senegal
2
South Sudan
2
China
2
Sudan
2
Benin
2
Yemen
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Russia
2
Mauritius
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Mozambique
1
Brazil
1
Serbia
1
Angola
1
Madagascar
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Southern Africa
1
Moldova
1
Australia
1
Turkmenistan
1
Maldives
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
272
Clinical Guidelines
53
Public Health
32
Pharmacy & Technologies
25
Key Resources
20
Women & Child Health
11
Capacity Building
4
Toolboxes
Pharmacy
81
AMR
76
COVID-19
56
HIV
37
Planetary Health
35
TB
28
Mental Health
21
Rapid Response
15
NTDs
13
NCDs
12
Global Health Education
11
Disability
10
Conflict
8
Specific Hazards
8
Ebola
7
Natural Hazards
6
Caregiver
5
Refugee
3
Health Financing Toolbox
2
Cholera
1
Polio
1
Zika
1
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc
...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in
...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may
...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R
...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man
...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect
...
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to
...
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
The Lancet Countdown is an international collaboration that independently monitors the health consequences of a changing climate. Publishing updated, new, and improved indicators each year, the Lancet Countdown represents the
consensus of leading researchers from 43 academic institutions and UN ag
...
Annex 5, WHO Technical Report Series 1010, 2018
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
